搜索临床试验以:Safety, tolerability and PK/PD
总计472071个结果
-
GeneScience Pharmaceuticals Co., Ltd.Affiliated Hospital of North Sichuan Medical College招聘中
-
Novartis Pharmaceuticals完全的
-
Vance Fowler, M.D.National Institute of Allergy and Infectious Diseases (NIAID)完全的
-
pH Pharma完全的
-
GlaxoSmithKline完全的
-
AstraZeneca完全的
-
AstraZeneca完全的健康受试者 | Safety, | Tolerability,英国
-
AstraZeneca完全的转移性去势抵抗性前列腺癌 (mCRPC), | 功效, | 安全性和耐受性, | 药代动力学, | 药效学, | 肿瘤反应。英国, 美国
-
Universitas PadjadjaranRadboud University Medical Center完全的
-
GlaxoSmithKline完全的
-
Spot Biosystems Ltd.Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University尚未招聘
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute尚未招聘
-
Daping Hospital and the Research Institute of Surgery...尚未招聘非小细胞肺癌 | 非小细胞肺癌 IIIB 期 | 表皮生长因子受体基因突变 | 非小细胞肺癌 IV 期
-
Ascendis Pharma Growth Disorders A/S尚未招聘
-
Ionis Pharmaceuticals, Inc.尚未招聘甲基 CpG 结合蛋白 2 (MECP2) 重复综合征
-
Regeneron Pharmaceuticals尚未招聘
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University of Roma La Sapienza 和其他合作者招聘中
-
Jules Bordet InstituteRayzeBio, Inc.尚未招聘多发性骨髓瘤复发 | 难治性多发性骨髓瘤 | 多发性骨髓瘤进展比利时
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University of Roma La Sapienza 和其他合作者招聘中
-
Bill & Melinda Gates Medical Research Institute尚未招聘
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University of Roma La Sapienza 和其他合作者招聘中
-
National Cancer Institute (NCI)尚未招聘
-
TOLREMO therapeutics AG招聘中